Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.
Ceramedix Holding has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in August 2023.
Ceramedix Holding's investors include National Institute of Allergy and Infectious Diseases.
Ceramedix Holding is headquartered in New York, United States.
Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.
Ceramedix Holding is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ceramedix Holding — Funding & Investors." VCBacked, August 24, 2023, https://www.vcbacked.co/company/ceramedix-holding. Accessed September 30, 2026.
VCBacked. (2023). Ceramedix Holding — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ceramedix-holding
{{cite web |title=Ceramedix Holding — Funding & Investors |url=https://www.vcbacked.co/company/ceramedix-holding |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated